Arcus Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Arcus Biosciences
RCUS Stock  USD 17.33  0.53  3.15%   
Arcus Biosciences financial statements provide useful quarterly and yearly information to potential Arcus Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Arcus Biosciences financial statements helps investors assess Arcus Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Arcus Biosciences' valuation are summarized below:
Gross Profit
-176 M
Profit Margin
(1.01)
Market Capitalization
1.6 B
Enterprise Value Revenue
2.5362
Revenue
247 M
There are over one hundred nineteen available fundamental signals for Arcus Biosciences, which can be analyzed over time and compared to other ratios. All traders should validate Arcus Biosciences' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 2.7 B in 2024. Enterprise Value is likely to gain to about 2.6 B in 2024

Arcus Biosciences Total Revenue

98.2 Million

Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 41 M, Interest Income of 43 M or Depreciation And Amortization of 16.8 M, as well as many indicators such as Price To Sales Ratio of 11.48, Dividend Yield of 0.0 or PTB Ratio of 3.39. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Arcus Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets767.6 M1.1 B467.2 M
Slightly volatile
Other Current Liabilities68.2 M65 M15 M
Slightly volatile
Total Current Liabilities99.4 M184 M57 M
Slightly volatile
Total Stockholder Equity428.3 M462 M276 M
Slightly volatile
Other Liabilities456.4 M434.7 M131.1 M
Slightly volatile
Property Plant And Equipment Net39.5 M51 M25.2 M
Slightly volatile
Accounts Payable10.8 M17 M7.5 M
Slightly volatile
Cash130.2 M127 M97.9 M
Slightly volatile
Non Current Assets Total211.7 M264 M120.8 M
Slightly volatile
Non Currrent Assets Other113 M106 M62.5 M
Slightly volatile
Other Assets8.5 M16.1 M5.4 M
Slightly volatile
Cash And Short Term Investments554.5 M759 M345.4 M
Slightly volatile
Net Receivables39.9 M42 M58.4 M
Slightly volatile
Common Stock Shares Outstanding57.8 M74 M41.7 M
Slightly volatile
Short Term Investments380.7 M632 M223.4 M
Slightly volatile
Liabilities And Stockholders Equity767.6 M1.1 B467.2 M
Slightly volatile
Non Current Liabilities Total239.9 M449 M134.2 M
Slightly volatile
Capital Surpluse1.4 B1.3 B428.8 M
Slightly volatile
Other Current Assets16.1 M30 M9 M
Slightly volatile
Total Liabilities339.3 M633 M191.2 M
Slightly volatile
Property Plant And Equipment Gross47.6 M82 M29.7 M
Slightly volatile
Preferred Stock Total Equity190.1 M260.1 M176.2 M
Slightly volatile
Total Current Assets555.9 M831 M346.4 M
Slightly volatile
Non Current Liabilities Other140 M142 M77.3 M
Slightly volatile
Property Plant Equipment163 M155.2 M39.2 M
Slightly volatile
Current Deferred Revenue60.2 M91 M31.9 M
Slightly volatile
Common Stock Total Equity5.3 K8.1 K4.4 K
Slightly volatile
Deferred Long Term Liabilities2.6 M2.7 M4.2 M
Pretty Stable
Net Invested Capital473.8 M462 M304.4 M
Slightly volatile
Net Working Capital598.2 M647 M370.3 M
Slightly volatile
Short Term Debt18 M11 M10.3 M
Slightly volatile
Capital Stock1.4 B1.3 B259.6 M
Slightly volatile
Short and Long Term Debt Total10.4 M11 M28.4 M
Slightly volatile
Capital Lease Obligations10.4 M11 M20.6 M
Pretty Stable

Arcus Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income41 M39 M7.2 M
Slightly volatile
Interest Income43 M41 M7.6 M
Slightly volatile
Depreciation And Amortization16.8 M16 M5.2 M
Slightly volatile
Selling General Administrative122.8 M117 M35.5 M
Slightly volatile
Other Operating Expenses479.9 M457 M147.2 M
Slightly volatile
Research Development357 M340 M111.7 M
Slightly volatile
Cost Of Revenue15.2 M16 M32.4 M
Pretty Stable
Total Operating Expenses479.9 M457 M147.2 M
Slightly volatile
Total Other Income Expense Net41 M39 M6.8 M
Slightly volatile
Reconciled Depreciation5 M8 M3.7 M
Slightly volatile
Non Operating Income Net Other339.4 K357.3 K3.6 M
Slightly volatile
Selling And Marketing Expenses13.6 M15.3 M16.7 M
Slightly volatile

Arcus Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation76.7 M73 M20.4 M
Slightly volatile
Begin Period Cash Flow120.1 M209 M85 M
Slightly volatile
Other Cashflows From Financing Activities7.6 M8 M45.5 M
Slightly volatile
Depreciation4.6 M8 M3 M
Slightly volatile
Capital Expenditures25.2 M24 M8.7 M
Slightly volatile
Change To Operating Activities27.8 M26.4 M7.8 M
Slightly volatile
Total Cash From Financing Activities36.1 M38 M100.8 M
Pretty Stable
End Period Cash Flow131.5 M130 M98.6 M
Slightly volatile
Change To Netincome91.8 M87.4 M23.1 M
Slightly volatile
Issuance Of Capital Stock34.2 M36 M125 M
Very volatile
Dividends Paid4 M4.5 M4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio11.4812.0803282
Slightly volatile
PTB Ratio3.393.05933.5501
Slightly volatile
Days Sales Outstanding11513177.6253
Slightly volatile
Book Value Per Share5.496.24325.6437
Slightly volatile
Stock Based Compensation To Revenue0.340.62390.3891
Slightly volatile
Capex To Depreciation6.416.113.4885
Slightly volatile
PB Ratio3.393.05933.5501
Slightly volatile
EV To Sales10.5311.0889244
Slightly volatile
Payables Turnover0.890.94123.2739
Pretty Stable
Sales General And Administrative To Revenue1.91.073.4115
Slightly volatile
Research And Ddevelopement To Revenue2.762.90619.2982
Slightly volatile
Capex To Revenue0.190.20512.1603
Slightly volatile
Cash Per Share6.4610.25686.3506
Slightly volatile
Days Payables Outstanding430388667
Slightly volatile
Current Ratio4.294.516312.5321
Slightly volatile
Tangible Book Value Per Share5.496.24325.6437
Slightly volatile
Receivables Turnover2.652.785748.0427
Slightly volatile
Graham Number13.2224.140712.9643
Slightly volatile
Shareholders Equity Per Share5.496.24325.6437
Slightly volatile
Debt To Equity0.280.26190.084
Slightly volatile
Capex Per Share0.340.32430.1809
Slightly volatile
Revenue Per Share1.221.58110.8095
Slightly volatile
Interest Debt Per Share1.751.66220.6321
Slightly volatile
Debt To Assets0.120.11050.0456
Slightly volatile
Price Book Value Ratio3.393.05933.5501
Slightly volatile
Days Of Payables Outstanding430388667
Slightly volatile
Ebt Per Ebit1.060.88530.9775
Pretty Stable
Company Equity Multiplier1.262.37011.365
Slightly volatile
Long Term Debt To Capitalization0.20.19230.066
Slightly volatile
Total Debt To Capitalization0.220.20750.0713
Slightly volatile
Debt Equity Ratio0.280.26190.084
Slightly volatile
Quick Ratio4.294.516312.9015
Slightly volatile
Net Income Per E B T0.781.01990.9125
Pretty Stable
Cash Ratio0.660.69026.7639
Slightly volatile
Days Of Sales Outstanding11513177.6253
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.211.07841.1924
Slightly volatile
Price To Book Ratio3.393.05933.5501
Slightly volatile
Fixed Asset Turnover1.612.29411.1029
Slightly volatile
Debt Ratio0.120.11050.0456
Slightly volatile
Price Sales Ratio11.4812.0803282
Slightly volatile
Asset Turnover0.07340.10680.0512
Slightly volatile
Price Fair Value3.393.05933.5501
Slightly volatile

Arcus Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.7 B2.5 B1.1 B
Slightly volatile
Enterprise Value2.6 B2.5 B1 B
Slightly volatile

Arcus Fundamental Market Drivers

Cash And Short Term Investments759 M

Arcus Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue91 M60.2 M
Total Revenue117 M98.2 M
Cost Of Revenue16 M15.2 M
Stock Based Compensation To Revenue 0.62  0.34 
Sales General And Administrative To Revenue 1.07  1.90 
Research And Ddevelopement To Revenue 2.91  2.76 
Capex To Revenue 0.21  0.19 
Revenue Per Share 1.58  1.22 
Ebit Per Revenue(2.91)(3.05)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY